{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:33:20Z","timestamp":1794004400862,"version":"4.8.0"},"reference-count":372,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Neuroinflammation represents a common trait in the pathology and progression of the major psychiatric and neurodegenerative disorders. Neuropsychiatric disorders have emerged as a global crisis, affecting 1 in 4 people, while neurological disorders are the second leading cause of death in the elderly population worldwide (<jats:xref>WHO, 2001<\/jats:xref>;<jats:xref>GBD 2016 Neurology Collaborators, 2019<\/jats:xref>). However, there remains an immense deficit in availability of effective drug treatments for most neurological disorders. In fact, for disorders such as depression, placebos and behavioral therapies have equal effectiveness as antidepressants. For neurodegenerative diseases such as Parkinson\u2019s disease and Alzheimer\u2019s disease, drugs that can prevent, slow, or cure the disease have yet to be found. Several non-traditional avenues of drug target identification have emerged with ongoing neurological disease research to meet the need for novel and efficacious treatments. Of these novel avenues is that of neuroinflammation, which has been found to be involved in the progression and pathology of many of the leading neurological disorders. Neuroinflammation is characterized by glial inflammatory factors in certain stages of neurological disorders. Although the meta-analyses have provided evidence of genetic\/proteomic upregulation of inflammatory factors in certain stages of neurological disorders. Although the mechanisms underpinning the connections between neuroinflammation and neurological disorders are unclear, and meta-analysis results have shown high sensitivity to factors such as disorder severity and sample type, there is significant evidence of neuroinflammation associations across neurological disorders. In this review, we summarize the role of neuroinflammation in psychiatric disorders such as major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and bipolar disorder, as well as in neurodegenerative disorders, such as Parkinson\u2019s disease and Alzheimer\u2019s disease, and introduce current research on the potential of immunomodulatory imide drugs (IMiDs) as a new treatment strategy for these disorders.<\/jats:p>","DOI":"10.3389\/fnins.2021.656921","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T04:26:53Z","timestamp":1616992013000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders"],"prefix":"10.3389","volume":"15","author":[{"given":"Yoo Jin","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweedie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Scerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Palmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusta","family":"Pisanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease.","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/wnl.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson\u2019s disease.","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jnc.13087","article-title":"Neuroprotective effects of vildagliptin in rat rotenone Parkinson\u2019s disease model: role of RAGE-NF\u03baB and Nrf2-antioxidant signaling pathways.","volume":"133","author":"Abdelsalam","year":"2015","journal-title":"J. Neurochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr. Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155100","article-title":"Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis.","volume":"131","author":"Almeida","year":"2020","journal-title":"Cytokine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/mp.2010.101","article-title":"Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys.","volume":"16","author":"Alonso","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41589-019-0366-7","article-title":"p63 is a cereblon substrate involved in thalidomide teratogenicity.","volume":"15","author":"Asatsuma-Okumura","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ph13050095","article-title":"Molecular mechanisms of the teratogenic effects of thalidomide.","volume":"13","author":"Asatsuma-Okumura","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JPD-181329","article-title":"What effects might exenatide have on non-motor symptoms in Parkinson\u2019s disease: a post hoc analysis.","volume":"8","author":"Athauda","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JPD-140364","article-title":"Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson\u2019s disease.","volume":"4","author":"Aviles-Olmos","year":"2014","journal-title":"J. Parkinsons. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","article-title":"Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson\u2019s disease.","volume":"25","author":"Badawi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease.","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/a:1018567510105","article-title":"PK (\u2018peripheral benzodiazepine\u2019)\u2013binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia.","volume":"26","author":"Banati","year":"1997","journal-title":"J. Neurocytol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/15622975.2016.1190867","article-title":"Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition Europe PMC funders group.","volume":"18","author":"Bandelow","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4155\/fmc-2018-0436","article-title":"Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide.","volume":"11","author":"Banks","year":"2019","journal-title":"Future Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1471-4159.2011.07377.x","article-title":"Tumor necrosis factor-a synthesis inhibitor, 3,6\u2019-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice.","volume":"118","author":"Baratz","year":"2011","journal-title":"J. Neurochem."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0237-4","article-title":"Transiently lowering tumor necrosis factor-\u03b1 synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice.","volume":"12","author":"Baratz","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0000000000000616","article-title":"Traumatic brain injury and risk of dementia in older veterans.","volume":"83","author":"Barnes","year":"2014","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuroscience.2008.07.016","article-title":"Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.","volume":"156","author":"Barnum","year":"2008","journal-title":"Neuroscience"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease.","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","article-title":"[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease?","volume":"16","author":"Bartels","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease.","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/s0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism.","volume":"113","author":"Bas","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030502","article-title":"Post-injury neuroprotective effects of the thalidomide analog 3,6\u2019-dithiothalidomide on traumatic brain injury.","volume":"20","author":"Batsaikhan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biopsych.2009.11.004","article-title":"The interleukin 1 Beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.","volume":"67","author":"Baune","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JPD-160888","article-title":"Multicenter assessment of immunohistochemical methods for pathological alpha-synuclein in sigmoid colon of autopsied parkinson\u2019s disease and control subjects.","volume":"6","author":"Beach","year":"2016","journal-title":"J. Parkinsons. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1126\/science.1067859","article-title":"Control of synaptic strength by glial TNFalpha.","volume":"295","author":"Beattie","year":"2002","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1468-1331.2011.03399.x","article-title":"NSAID use and risk of Parkinson disease: a population-based case-control study.","volume":"18","author":"Becker","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000446","article-title":"Lost in translation: neuropsychiatric drug development.","volume":"2","author":"Becker","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59542-x","article-title":"Thalidomide inhibits human iPSC mesendoderm differentiation by modulating CRBN-dependent degradation of SALL4.","volume":"10","author":"Belair","year":"2020","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2174\/1871527315666160321104749","article-title":"Disease-induced neuroinflammation and depression.","volume":"15","author":"Benatti","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00071","article-title":"Neuroinflammation in bipolar depression.","volume":"11","author":"Benedetti","year":"2020","journal-title":"Front. Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble.","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/mds.27799","article-title":"Immunomodulatory drugs alleviate L-dopa-induced dyskinesia in a rat model of Parkinson\u2019s disease.","volume":"34","author":"Boi","year":"2019","journal-title":"Mov. Disord."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228535","article-title":"Modeling Parkinson\u2019s disease neuropathology and symptoms by intranigral inoculation of preformed human \u03b1-synuclein oligomers.","volume":"21","author":"Boi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nbd.2014.10.017","article-title":"Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson\u2019s disease.","volume":"73","author":"Bortolanza","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.neurobiolaging.2014.03.017","article-title":"Raloxifene activates G protein-coupled estrogen receptor 1\/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.","volume":"35","author":"Bourque","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/mds.27128","article-title":"Glitazone use associated with reduced risk of Parkinson\u2019s disease.","volume":"32","author":"Brakedal","year":"2017","journal-title":"Mov. Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","article-title":"TNF-\u03b1 as a molecular target in bipolar disorder.","volume":"32","author":"Brietzke","year":"2008","journal-title":"Prog. NeuroPsychopharmacol. Biol. Psychiatry"},{"key":"B40","year":"2020","journal-title":"U.S. Food and Drug Administration Approves Bristol Myers Squibb\u2019s Pomalyst\u00a7(pomalidomide) for AIDS-Related and HIV-Negative Kaposi Sarcoma."},{"key":"B41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1210\/endo.141.10.7693","article-title":"Antiinflammatory effects of estrogen on microglial activation.","volume":"141","author":"Bruce-Keller","year":"2000","journal-title":"Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbi.2012.04.009","article-title":"The role of immune genes in the association between depression and inflammation: a review of recent clinical studies.","volume":"31","author":"Bufalino","year":"2013","journal-title":"Brain. Behav. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.3233\/JIN-170072","article-title":"Fish oil and depression: the skinny on fats.","volume":"16","author":"Burhani","year":"2017","journal-title":"J. Integr. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2017.0032","article-title":"Can we use mice to study schizophrenia?","volume":"373","author":"Canetta","year":"2018","journal-title":"Philos. Trans. R. Soc. London. Ser. B Biol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/brain\/awu318","article-title":"Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer\u2019s disease.","volume":"138","author":"Cantarella","year":"2015","journal-title":"Brain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/dom.13373","article-title":"Comparative efficacy and acceptability of antidiabetic agents for Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and network meta-analysis.","volume":"20","author":"Cao","year":"2018","journal-title":"Diabetes. Obes. Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1176\/ajp.128.1.31","article-title":"Adrenal cortical activity in depressive illness.","volume":"128","author":"Carpenter","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1389450111314070004","article-title":"PPAR-\u03b3: therapeutic prospects in Parkinson\u2019s disease.","volume":"14","author":"Carta","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108685","article-title":"Advances in modelling alpha-synuclein-induced Parkinson\u2019s diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species.","volume":"338","author":"Carta","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"B51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/ejn.13482","article-title":"l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?","volume":"45","author":"Carta","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","article-title":"Evidence for astrocytosis in prodromal alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.","volume":"53","author":"Carter","year":"2012","journal-title":"J. Nucl. Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00031","article-title":"Neuroprotection by the immunomodulatory drug pomalidomide in the Drosophila LRRK2WD40 genetic model of Parkinson\u2019s disease.","volume":"12","author":"Casu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B54","author":"Cavalcante Passos","year":"2015","journal-title":"Infl Ammatory Markers in Post-Traumatic Stress Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression."},{"key":"B55","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs.","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01095-8","article-title":"A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis.","volume":"10","author":"Chaudhry","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neulet.2013.02.005","article-title":"The contribution of TNF-in the amygdala to anxiety in mice with persistent inflammatory pain.","volume":"541","author":"Chen","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00218","article-title":"Gut Inflammation in association with pathogenesis of Parkinson\u2019s disease.","volume":"12","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2019.06.006","article-title":"Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson\u2019s disease.","volume":"414","author":"Churchill","year":"2019","journal-title":"Neuroscience"},{"key":"B61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pharmthera.2010.08.007","article-title":"The roles of TNF in brain dysfunction and disease.","volume":"128","author":"Clark","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1111\/bph.14471","article-title":"Therapeutic implications of how TNF links APOE, P-tau, \u03b1-synuclein, \u03b2-amyloid, and insulin resistance in neurodegenerative diseases.","volume":"175","author":"Clark","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bmcl.2008.11.118","article-title":"Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.","volume":"19","author":"Contino-P\u00e9pin","year":"2009","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/549691","article-title":"PPAR\u03b3 and the innate immune system mediate the resolution of inflammation.","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition.","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","article-title":"Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions.","volume":"54","author":"Crowley","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis.","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","article-title":"NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 cotzias lecture.","volume":"87","author":"Dalmau","year":"2016","journal-title":"Neurology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders.","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases.","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1567205014666170117141330","article-title":"Poor safety and tolerability hamper reaching a potentially therapeutic dose in the use of thalidomide for Alzheimer\u2019s disease: results from a double-blind, placebo-controlled trial.","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1567205013666160930","article-title":"Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease.","volume":"14","author":"Decourt","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/oajct.s221914","article-title":"MCLENA-1: a phase II clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to Alzheimer\u2019s disease.","volume":"12","author":"Decourt","year":"2020","journal-title":"Open Access J. Clin. Trials"},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease.","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1554-9","article-title":"Beneficial effects of curtailing immune susceptibility in an Alzheimer\u2019s disease model.","volume":"16","author":"Di Benedetto","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.expneurol.2010.04.007","article-title":"Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).","volume":"226","author":"do Amaral Corr\u00eaa","year":"2010","journal-title":"Exp. Neurol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009831.pub2","article-title":"Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.","volume":"1","author":"Dold","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1523\/JNEUROSCI.3968-13.2014","article-title":"A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex.","volume":"34","author":"Donegan","year":"2014","journal-title":"J. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/cns.12390","article-title":"Glial pathology in bipolar disorder: potential therapeutic implications.","volume":"21","author":"Dong","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3238165","article-title":"Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life.","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112451","article-title":"Optimal linker length for small molecule PROTACs that selectively target p38\u03b1 and p38\u03b2 for degradation.","volume":"201","author":"Donoghue","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in duane radial ray syndrome.","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0090-1","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients.","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression.","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00719","article-title":"LRRK2 and protein aggregation in Parkinson\u2019s disease: insights from animal models.","volume":"14","author":"Dues","year":"2020","journal-title":"Front. Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology.","volume":"133","author":"Dzamko","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of danish national registers.","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis.","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160923","article-title":"The anti-inflammatory effects of blueberries in an animal model of post-traumatic stress disorder (PTSD).","volume":"11","author":"Ebenezer","year":"2016","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia.","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00625","article-title":"In vivo imaging of glial activation in alzheimer\u2019s disease.","volume":"9","author":"Edison","year":"2018","journal-title":"Front. Neurol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.expneurol.2015.08.008","article-title":"Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.","volume":"273","author":"Eitan","year":"2015","journal-title":"Exp. Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/10520295.2012.744471","article-title":"Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats.","volume":"88","author":"El\u00e7ioglu","year":"2013","journal-title":"Biotech. Histochem."},{"key":"B95","first-page":"201","article-title":"Anxiety and depression in patients with coronary heart disease: a study in a tertiary hospital.","volume":"36","author":"Eng","year":"2011","journal-title":"Iran J. Med. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology.","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/08830189809084493","article-title":"Cytokines in autoimmune disorders.","volume":"17","author":"Feldmann","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-065X.2008.00626.x","article-title":"Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.","volume":"223","author":"Feldmann","year":"2008","journal-title":"Immunol. Rev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"i97","DOI":"10.1136\/ard.2009.117143","article-title":"What have we learnt from targeted anti-TNF therapy?","volume":"69","author":"Feldmann","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","article-title":"Imaging the role of inflammation in mood and anxiety-related disorders.","volume":"16","author":"Felger","year":"2018","journal-title":"Curr Neuropharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.biopsych.2020.04.024","article-title":"Identifying immunophenotypes of inflammation in depression: dismantling the monolith.","volume":"88","author":"Felger","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia.","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"B103","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-\u03b1) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.","volume":"89","author":"Ferger","year":"2004","journal-title":"J. Neurochem."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00014","article-title":"The role of apoE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease.","volume":"10","author":"Fernandez","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.psyneuen.2018.11.035","article-title":"Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress.","volume":"102","author":"Fiksdal","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide.","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1818","article-title":"Mouse models of neurodegeneration: know your question, know your mouse.","volume":"11","author":"Fisher","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbi.2018.11.316","article-title":"Brain tumor necrosis factor-\u03b1 mediates anxiety-like behavior in a mouse model of severe obesity.","volume":"77","author":"Fourrier","year":"2019","journal-title":"Brain. Behav. Immun."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"B110","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/187152711794653751","article-title":"Targeting TNF-\u03b1 to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.","volume":"10","author":"Frankola","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B111","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","article-title":"Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice.","volume":"7","author":"Fratta","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis.","volume":"86","author":"Friedman","year":"2019","journal-title":"Jt. Bone Spine."},{"key":"B113","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/neu.2009.1120","article-title":"In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.","volume":"27","author":"Frugier","year":"2010","journal-title":"J. Neurotrauma"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137305","article-title":"Oral TNF\u03b1 modulation alters neutrophil infiltration, improves cognition and diminishes tau and amyloid pathology in the 3xTgAD mouse model.","volume":"10","author":"Gabbita","year":"2015","journal-title":"PLoS One"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-99","article-title":"Early intervention with a small molecule inhibitor for tumor nefosis factor-\u03b1 prevents cognitive deficits in a triple transgenic mouse model of Alzheimer\u2019s disease.","volume":"9","author":"Gabbita","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br. J. Haematol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease.","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","article-title":"Epidemiology of mild traumatic brain injury and neurodegenerative disease.","volume":"66","author":"Gardner","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1073\/pnas.1814446115","article-title":"Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs.","volume":"115","author":"Gemechu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-017-0013-5","article-title":"Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson\u2019s disease trial.","volume":"3","author":"Gendelman","year":"2017","journal-title":"NPJ Park. Dis."},{"key":"B122","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/SHK.0b013e318162d290","article-title":"Effect of thalidomide on signal transduction pathways and secondary damage in experimental spinal cord trauma.","volume":"30","author":"Genovese","year":"2008","journal-title":"Shock"},{"key":"B123","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease.","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0022-3956(62)90006-7","article-title":"Plasma cortisol in depressive illness.","volume":"1","author":"Gibbons","year":"1962","journal-title":"J. Psychiatr. Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1744-6163.2009.00229.x","article-title":"PTSD is associated with an excess of inflammatory immune activities.","volume":"45","author":"Gill","year":"2009","journal-title":"Perspect. Psychiatr. Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.npp.1300446","article-title":"Prenatal infection and risk for schizophrenia: IL-1\u03b2, IL-6, and TNF\u03b1 inhibit cortical neuron dendrite development.","volume":"29","author":"Gilmore","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.","volume":"10","author":"Glass","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression HHS public access.","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-5","article-title":"Interleukin-1 mediates Alzheimer and lewy body pathologies.","volume":"3","author":"Griffin","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"B131","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients.","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B132","first-page":"27","article-title":"Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?","volume":"6","author":"Grunebaum","year":"2007","journal-title":"Curr. Psychiatr."},{"key":"B133","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder.","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"B134","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.placenta.2008.10.012","article-title":"Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.","volume":"30","author":"Haider","year":"2009","journal-title":"Placenta"},{"key":"B135","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/glia.23529","article-title":"Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders.","volume":"67","author":"Han","year":"2019","journal-title":"Glia"},{"key":"B136","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective.","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.","volume":"192","author":"Haslett","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1113\/jphysiol.2010.199778","article-title":"Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse.","volume":"588","author":"Haustein","year":"2010","journal-title":"J. Physiol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055091","article-title":"Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of \u03b2-secretase in a mouse model of Alzheimer\u2019s disease.","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"B141","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease.","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease.","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.","volume":"5","author":"Henry","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"B144","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","article-title":"Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies.","volume":"40","author":"Hirsch","year":"2017","journal-title":"Drug Saf."},{"key":"B145","doi-asserted-by":"publisher","first-page":"10","DOI":"10.9758\/CPN.2020.18.1.10","article-title":"Anti-inflammatory strategies for schizophrenia: a review of evidence for therapeutic applications and drug repurposing.","volume":"18","author":"Hong","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00151","article-title":"The role of indoleamine-2,3-dioxygenase in cancer development, diagnostics, and therapy.","volume":"9","author":"Horny\u00e1k","year":"2018","journal-title":"Front. Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"B149","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.1c00042","article-title":"N-adamantyl phthalimidine, a new thalidomide-like drug that lacks cereblon binding, mitigates neuronal and synaptic loss, neuroinflammation and behavioral deficits in traumatic brain injury and LPS challenge.","author":"Hsueh","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00480","article-title":"CSF cytokines in aging, multiple sclerosis, and dementia.","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1177\/0269881117725711","article-title":"Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis.","volume":"31","author":"Husain","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"B152","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/NRE-2007-22502","article-title":"The impact of traumatic brain injuries: a global perspective.","volume":"22","author":"Hyder","year":"2007","journal-title":"NeuroRehabilitation"},{"key":"B153","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","article-title":"In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease.","volume":"19","author":"Iannaccone","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B154","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains.","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12185-016-2073-4","article-title":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs.","volume":"104","author":"Ito","year":"2016","journal-title":"Int. J. Hematol."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.037","article-title":"NSAIDs are associated with lower depression scores in patients with osteoarthritis.","volume":"126","author":"Iyengar","year":"2013","journal-title":"Am. J. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis.","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B158","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/978-981-32-9721-0_24","article-title":"Role of inflammation in psychiatric disorders.","volume":"1192","author":"Jeon","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00313","article-title":"Neuroinflammation as a factor of neurodegenerative disease: thalidomide analogs as treatments.","volume":"7","author":"Jung","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.neuron.2008.04.023","article-title":"Tumor necrosis factor-\u03b1 mediates one component of competitive, experience-dependent plasticity in developing visual cortex.","volume":"58","author":"Kaneko","year":"2008","journal-title":"Neuron"},{"key":"B161","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B162","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/19420862.2018.1465159","article-title":"Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.","volume":"10","author":"Karaoglu Hanzatian","year":"2018","journal-title":"MAbs"},{"key":"B163","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/187152412800229125","article-title":"Targeting vascular changes in lesions in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"12","author":"Karlik","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"B164","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","article-title":"Interleukin-1\u03b2 interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease.","volume":"327","author":"Karpenko","year":"2018","journal-title":"Cell. Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models.","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"B166","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bdi.12772","article-title":"New drug candidates for bipolar disorder\u2014A nation-wide population-based study.","volume":"21","author":"Kessing","year":"2019","journal-title":"Bipolar Disord."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson\u2019s disease.","volume":"202","author":"Kim","year":"2009","journal-title":"J. Endocrinol."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9020107","article-title":"Inflammation in post-traumatic stress disorder (PTSD): a review of potential correlates of PTSD with a neurological perspective.","volume":"9","author":"Kim","year":"2020","journal-title":"Antioxidants"},{"key":"B170","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"B171","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbr.2017.04.020","article-title":"The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder.","volume":"329","author":"Kim","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00407","article-title":"Placebo effect in the treatment of depression and anxiety.","volume":"10","author":"Kirsch","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B173","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease.","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia.","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B175","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15570\/actaapa.2018.38","article-title":"psychodermatology: a molecular link between psoriasis and anxiety disorder.","volume":"27","author":"Klimov","year":"2018","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"B176","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/1570159x14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment.","volume":"14","author":"Kohler","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/acps.13016","article-title":"Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.","volume":"139","author":"K\u00f6hler-Forsberg","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"B178","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jnc.14575","article-title":"Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson\u2019s disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.","volume":"147","author":"Komnig","year":"2018","journal-title":"J. Neurochem."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys.","volume":"54","author":"Konitsiotis","year":"2000","journal-title":"Neurology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.expneurol.2009.01.005","article-title":"Acute rolipram\/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury.","volume":"216","author":"Koopmans","year":"2009","journal-title":"Exp. Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2009.07.001","article-title":"Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival.","volume":"30","author":"Kraft","year":"2009","journal-title":"Neurotoxicology"},{"key":"B183","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry.","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"B184","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s007020070078","article-title":"Genetic analysis of immunomodulating factors in sporadic Parkinson\u2019s disease.","volume":"107","author":"Kr\u00fcger","year":"2000","journal-title":"J. Neural Transm."},{"key":"B185","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.acthis.2014.12.002","article-title":"Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats.","volume":"117","author":"K\u00fcbra El\u00e7io\u011flu","year":"2015","journal-title":"Acta Histochem."},{"key":"B186","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.pbr.2020.02.004","article-title":"The role of glia in Parkinson\u2019s disease: emerging concepts and therapeutic applications.","volume":"252","author":"Kuter","year":"2020","journal-title":"Prog. Brain Res."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: a systematic review and meta-analysis.","volume":"14","author":"Ku\u017ama","year":"2018","journal-title":"Alzheimers. Dement."},{"key":"B188","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1111\/bph.14214","article-title":"Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPAR\u03b3 agonist MDG548 in Parkinson\u2019s disease models.","volume":"175","author":"Lecca","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfr086","article-title":"Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.","volume":"122","author":"Lee","year":"2011","journal-title":"Toxicol. Sci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4049\/jimmunol.0903480","article-title":"Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.","volume":"185","author":"Lee","year":"2010","journal-title":"J. Immunol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease.","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1893526","article-title":"Anti-neuroinflammatory effect of jaeumganghwa-tang in an animal model of amyotrophic lateral sclerosis.","volume":"2019","author":"Lee","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B193","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study.","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"B194","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.neuron.2016.03.030","article-title":"Microglial TNF-\u03b1 suppresses cocaine-induced plasticity and behavioral sensitization.","volume":"90","author":"Lewitus","year":"2016","journal-title":"Neuron"},{"key":"B195","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/01616412.2018.1474840","article-title":"Sitagliptin rescues memory deficits in Parkinsonian rats via upregulating BDNF to prevent neuron and dendritic spine loss.","volume":"40","author":"Li","year":"2018","journal-title":"Neurol. Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","article-title":"Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54726","article-title":"3,6\u2019-Dithiopomalidomide Reduces Neural Loss, Inflammation, Behavioral Deficits in Brain Injury and Microglial Activation.","volume":"9","author":"Lin","year":"2020","journal-title":"Elife"},{"key":"B199","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbi.2014.06.003","article-title":"Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress.","volume":"42","author":"Lindqvist","year":"2014","journal-title":"Brain. Behav. Immun."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological targeting of microglial activation: new therapeutic approach.","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00213-018-5148-5","article-title":"Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice.","volume":"236","author":"Liu","year":"2019","journal-title":"Psychopharmacology"},{"key":"B202","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1523\/JNEUROSCI.2235-16.2016","article-title":"TNF-\u03b1 differentially regulates synaptic plasticity in the hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury.","volume":"37","author":"Liu","year":"2017","journal-title":"J. Neurosci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3233\/JAD-190028","article-title":"Traumatic brain injury and risk of long-term brain changes, accumulation of pathological markers, and developing dementia: a review.","volume":"70","author":"LoBue","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020206","article-title":"Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, creutzfeldt-jakob and tauopathies.","volume":"17","author":"L\u00f3pez Gonz\u00e1lez","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B205","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881116686883","article-title":"Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies.","volume":"31","author":"Lopresti","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4.","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson\u2019s disease and the gastrointestinal microbiome.","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.bmc.2018.01.032","article-title":"Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-\u03b1 and angiogenesis inhibitory activities.","volume":"26","author":"Luo","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1016\/j.bmc.2011.05.029","article-title":"Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-\u03b1 inhibitory activity.","volume":"19","author":"Luo","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"B210","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer\u2019s disease.","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.pharep.2018.11.005","article-title":"PPAR-\u03b3 agonist pioglitazone reduces microglial proliferation and NF-\u03baB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson\u2019s disease.","volume":"71","author":"Machado","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"B212","doi-asserted-by":"publisher","first-page":"12703","DOI":"10.1073\/pnas.1307684110","article-title":"Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro.","volume":"110","author":"Mahony","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease.","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B214","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2016.04.012","article-title":"Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.","volume":"308","author":"Majkutewicz","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/GME.0000000000001174","article-title":"Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.","volume":"25","author":"Maki","year":"2018","journal-title":"Menopause"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-894x(03)00778-9","article-title":"Alpha-fluoro-substituted thalidomide analogues.","volume":"13","author":"Man","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0158-z","article-title":"Defining the contribution of neuroinflammation to Parkinson\u2019s disease in humanized immune system mice.","volume":"12","author":"Manocha","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"B218","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nbd.2014.11.024","article-title":"Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.","volume":"74","author":"Martinez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.4103\/1673-5374.237108","article-title":"Neuroprotection by immunomodulatory agents in animal models of Parkinson\u2019s disease.","volume":"13","author":"Martinez","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B220","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga.","volume":"39","author":"Melchert","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression.","volume":"20","author":"Menard","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B224","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide A Lopez-Girona.","volume":"26","author":"Mendy","year":"2012","journal-title":"Leukemia"},{"key":"B225","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative.","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"B226","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond.","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B227","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target.","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.7205\/MILMED-D-17-00073","article-title":"The role of inflammation in late-life post-traumatic stress disorder.","volume":"182","author":"Miller","year":"2017","journal-title":"Mil Med."},{"key":"B229","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2017.02.006","article-title":"A Brighter Side to Thalidomide: its potential use in immunological disorders.","volume":"23","author":"Millrine","year":"2017","journal-title":"Trends Mol. Med."},{"key":"B230","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1182\/blood-2014-03-559641","article-title":"Physiological functions of TNF family receptor\/ligand interactions in hematopoiesis and transplantation.","volume":"124","author":"Mizrahi","year":"2014","journal-title":"Blood"},{"key":"B231","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review.","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front. psychiatry"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.","volume":"177","author":"Moreira","year":"1993","journal-title":"J. Exp. Med."},{"key":"B234","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00075198-200204000-00002","article-title":"Inflammatory response in acute traumatic brain injury: a double-edged sword.","volume":"8","author":"Morganti-Kossmann","year":"2002","journal-title":"Curr. Opin. Crit. Care"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19202-7","article-title":"Structural basis of thalidomide enantiomer binding to cereblon.","volume":"8","author":"Mori","year":"2018","journal-title":"Sci. Rep."},{"key":"B236","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0197-0186(98)00026-6","article-title":"Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6.","volume":"33","author":"M\u00f6ssner","year":"1998","journal-title":"Neurochem. Int."},{"key":"B237","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson\u2019s disease by activation of sphingosine kinase 1 and Akt kinase.","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"B238","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson\u2019s disease.","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp. Neurol."},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.614643","article-title":"Repositioning of immunomodulators: a ray of hope for Alzheimer\u2019s disease?","volume":"14","author":"Munaf\u00f2","year":"2020","journal-title":"Front. Neurosci."},{"key":"B240","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: role of inflammation and the development of disease biomarkers.","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry Investig."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"B242","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.expneurol.2014.08.019","article-title":"Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson\u2019s disease. Involvement of vascular endothelial growth factor and interleukin-1\u03b2.","volume":"261","author":"Mu\u00f1oz","year":"2014","journal-title":"Exp. Neurol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuropharm.2014.10.007","article-title":"Saxagliptin: a novel antiparkinsonian approach.","volume":"89","author":"Nassar","year":"2015","journal-title":"Neuropharmacology"},{"key":"B244","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","article-title":"Rheumatoid arthritis and depression: an inflammatory perspective.","volume":"6","author":"Nerurkar","year":"2019","journal-title":"The Lancet Psychiatry"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders.","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(15)00144-1","article-title":"Pioglitazone in early Parkinson\u2019s disease: a phase. (2), multicentre, double-blind, randomised trial.","volume":"14","year":"2015","journal-title":"Lancet. Neurol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/1467-8721.00142","article-title":"Gender Differences in Depression.","volume":"10","author":"Nolen-Hoeksema","year":"2001","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"B248","author":"O\u2019Donovan","year":"2020","journal-title":"Inflammation and Threat Sensitivity in PTSD."},{"key":"B249","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1093\/brain\/awr165","article-title":"Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.","volume":"134","author":"Ohlin","year":"2011","journal-title":"Brain"},{"key":"B250","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11481-011-9282-7","article-title":"Rosiglitazone improves spatial memory and decreases insoluble A\u03b2(1-42) in APP\/PS1 mice.","volume":"7","author":"O\u2019Reilly","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease.","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"B252","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease.","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications.","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068612","article-title":"Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer\u2019s disease with combined amyloid-\u03b2 and cerebrovascular pathology.","volume":"8","author":"Papadopoulos","year":"2013","journal-title":"PLoS One"},{"key":"B255","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-a signaling in macrophages.","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier.","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B257","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11102-019-00957-9","article-title":"Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae.","volume":"22","author":"Pavlovic","year":"2019","journal-title":"Pituitary"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235683","article-title":"Antiangiogenic activity and in silico cereblon binding analysis of novel thalidomide analogs.","volume":"25","author":"Peach","year":"2020","journal-title":"Molecules"},{"key":"B259","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0960-0760(91)90312-S","article-title":"Steroids and depression.","volume":"38","author":"Pearson Murphy","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jad.2014.08.052","article-title":"General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.","volume":"170","author":"Perugi","year":"2015","journal-title":"J. Affect. Disord."},{"key":"B261","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-tumor necrosis factor therapy and incidence of parkinson disease among patients with inflammatory bowel disease.","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol."},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4CRBN ubiquitin ligase.","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"B263","year":"2019","journal-title":"Top-Selling Prescription Drugs by Revenue: Ranking the Top Ten."},{"key":"B264","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/1570159x15666170828170921","article-title":"Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder.","volume":"15","author":"Pinto","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0090-7","article-title":"Pioglitazone ameliorates the phenotype of a novel Parkinson\u2019s disease mouse model by reducing neuroinflammation.","volume":"11","author":"Pinto","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B266","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00702-018-1874-4","article-title":"Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.","volume":"125","author":"Pisanu","year":"2018","journal-title":"J. Neural Transm."},{"key":"B267","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease.","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges.","volume":"126","author":"Planchez","year":"2019","journal-title":"J. Neural Transm."},{"key":"B269","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","article-title":"Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease.","volume":"48","author":"Poirier","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B270","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol. Med."},{"key":"B271","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00228-018-2561-y","article-title":"Non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease in the elderly population: a meta-analysis.","volume":"75","author":"Poly","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"B273","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0753-3322(94)90003-5","article-title":"Cytokines as mediators in the central nervous system.","volume":"48","author":"Pousset","year":"1994","journal-title":"Biomed. Pharmacother."},{"key":"B274","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in parkinson disease: a systematic review and meta-analysis.","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"B275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","article-title":"Traumatic brain injury and Alzheimer\u2019s disease: the cerebrovascular link.","volume":"28","author":"Ramos-Cejudo","year":"2018","journal-title":"EBioMedicine"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.536257","article-title":"Cytokine imbalance in schizophrenia. From research to clinic: potential implications for treatment.","volume":"12","author":"Reale","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B277","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/0004867413499077","article-title":"Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application.","volume":"47","author":"Rege","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012172","article-title":"Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: a dose-response meta-analysis.","volume":"97","author":"Ren","year":"2018","journal-title":"Medicine"},{"key":"B279","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse parkinsonian models.","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem. Res."},{"key":"B280","doi-asserted-by":"crossref","first-page":"494","DOI":"10.55782\/ane-2009-1759","article-title":"Thalidomide fails to be therapeutic following contusive spinal cord injury in rats.","volume":"69","author":"Reyes-Alva","year":"2009","journal-title":"Acta Neurobiol. Exp."},{"key":"B281","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/wnl.45.1.51","article-title":"Nonsteroidal anti-inflammatory drugs in Alzheimer\u2019s disease.","volume":"45","author":"Rich","year":"1995","journal-title":"Neurology"},{"key":"B282","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2147\/DDDT.S115456","article-title":"Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.","volume":"11","author":"R\u00edos-Tamayo","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa109","article-title":"Anti-inflammatories in Alzheimer\u2019s disease-potential therapy or spurious correlate?","volume":"2","author":"Rivers-Auty","year":"2020","journal-title":"Brain Commun."},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8430123","article-title":"Tumor necrosis factor and interleukin-1\u03b2 modulate synaptic plasticity during neuroinflammation.","volume":"2018","author":"Rizzo","year":"2018","journal-title":"Neural Plast."},{"key":"B285","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0197-4580(88)80079-4","article-title":"Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease.","volume":"9","author":"Rogers","year":"1988","journal-title":"Neurobiol. Aging"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-44","article-title":"Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.","volume":"8","author":"Rojanathammanee","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"B287","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord."},{"key":"B288","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s004010000225","article-title":"Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.","volume":"100","author":"Rozemuller","year":"2000","journal-title":"Acta Neuropathol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1471-4159.2012.07846.x","article-title":"3,6\u2019-Dithiothalidomide, a new TNF-a synthesis inhibitor, attenuates the effect of A\u00df1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.","volume":"122","author":"Russo","year":"2012","journal-title":"Brain Physiol. Metab. Sect. Natl. Inst. Aging"},{"key":"B290","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2007.08.019","article-title":"Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-\u03b1 in an animal model of inflamed Alzheimer\u2019s disease brain.","volume":"29","author":"Ryu","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B291","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/art.27304","article-title":"Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.","volume":"62","author":"Sacre","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1096\/fj.03-1378fje","article-title":"Gene structure and organization of the human \u03b2-secretase (BACE) promoter.","volume":"18","author":"Sambamurti","year":"2004","journal-title":"FASEB J."},{"key":"B293","first-page":"16","article-title":"Psychiatric disorders: a global look at facts and figures.","volume":"7","author":"Sansone","year":"2010","journal-title":"Psychiatry"},{"key":"B294","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson\u2019s disease.","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201022","article-title":"Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model.","volume":"13","author":"Schiavon","year":"2018","journal-title":"PLoS One"},{"key":"B296","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-804766-8.00001-7","article-title":"Geriatric pharmacotherapy: appraising new drugs for neurologic disorders in older patients.","volume":"167","author":"Seeman","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"B299","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4088\/JCP.15m10370","article-title":"Side effects to antidepressant treatment in patients with depression and comorbid panic disorder.","volume":"78","author":"Shankman","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"B300","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clp.2006.03.010","article-title":"Hyperbilirubinemia and kernicterus.","volume":"33","author":"Shapiro","year":"2006","journal-title":"Clin. Perinatol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease.","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"B302","doi-asserted-by":"publisher","first-page":"220","DOI":"10.7861\/clinmedicine.17-3-220","article-title":"Developments in therapy with monoclonal antibodies and related proteins.","volume":"17","author":"Shepard","year":"2017","journal-title":"Clin. Med."},{"key":"B303","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions.","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9130608","article-title":"Cereblon: a protein crucial to the multiple functions of immunomodulatory drugs as well as cell metabolism and disease generation.","volume":"2017","author":"Shi","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B305","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","article-title":"CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson\u2019s disease.","volume":"16","author":"Shimoji","year":"2009","journal-title":"Neurotox. Res."},{"key":"B306","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbrc.2012.07.086","article-title":"Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.","volume":"425","author":"Shiraishi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B307","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0165-5728(96)00181-6","article-title":"Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.","volume":"72","author":"Shohami","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00213-019-05326-9","article-title":"Stress, sex hormones, inflammation, and major depressive disorder: extending social signal transduction theory of depression to account for sex differences in mood disorders.","volume":"236","author":"Slavich","year":"2019","journal-title":"Psychopharmacology"},{"key":"B309","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s11064-010-0336-7","article-title":"Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death.","volume":"36","author":"Smith","year":"2011","journal-title":"Neurochem. Res."},{"key":"B310","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90266-2","article-title":"The macrophage theory of depression.","volume":"36","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00018-017-2701-z","article-title":"Master regulatory role of p63 in epidermal development and disease.","volume":"75","author":"Soares","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"B312","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/JIR.S155903","article-title":"Systemic low-grade inflammation in post-traumatic stress disorder: a systematic review.","volume":"11","author":"Speer","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"B313","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.4049\/jimmunol.152.6.3024","article-title":"Endogenous norepinephrine regulates tumor necrosis factor-\u03b1 production from macrophages in vitro.","volume":"152","author":"Spengler","year":"1994","journal-title":"J. Immunol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B315","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","article-title":"Divergent roles for tumor necrosis factor-\u03b1 in the brain.","volume":"2","author":"Sriram","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B316","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons.","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1021\/acschembio.8b00693","article-title":"Homo-PROTACs for the chemical knockdown of cereblon.","volume":"13","author":"Steinebach","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/nature04671","article-title":"Synaptic scaling mediated by glial TNF-alpha.","volume":"440","author":"Stellwagen","year":"2006","journal-title":"Nature"},{"key":"B319","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YCO.0b013e32835aa4b4","article-title":"Is bipolar disorder an inflammatory condition? the relevance of microglial activation.","volume":"26","author":"Stertz","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"B320","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.48.3.626","article-title":"Risk of Alzheimer\u2019s disease and duration of NSAID use.","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"B321","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","article-title":"A role for neuronal alpha-synuclein in gastrointestinal immunity.","volume":"9","author":"Stolzenberg","year":"2017","journal-title":"J. Innate Immun."},{"key":"B322","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides.","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"B323","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease.","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B324","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B325","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1021\/ol9902172","article-title":"(R)- and (S)-3-fluorothalidomides: isosteric analogues of thalidomide.","volume":"1","author":"Takeuchi","year":"1999","journal-title":"Org. Lett."},{"key":"B326","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention.","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00421","article-title":"Microglia gone rogue: impacts on psychiatric disorders across the lifespan.","volume":"10","author":"Tay","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B328","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","article-title":"Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study.","volume":"30","author":"Terada","year":"2016","journal-title":"Ann. Nucl. Med."},{"key":"B329","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1586\/ern.10.52","article-title":"Perispinal etanercept: a new therapeutic paradigm in neurology.","volume":"10","author":"Tobinick","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"B330","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40263-016-0339-2","article-title":"Perispinal delivery of CNS drugs.","volume":"30","author":"Tobinick","year":"2016","journal-title":"CNS Drugs"},{"key":"B331","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/14737175.2018.1468253","article-title":"Perispinal etanercept advances as a neurotherapeutic.","volume":"18","author":"Tobinick","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"B332","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease.","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"B333","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182152","article-title":"Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.","volume":"12","author":"Tokunaga","year":"2017","journal-title":"PLoS One"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0431-y","article-title":"Options for pharmacological treatment of refractory bipolar depression.","volume":"16","author":"Tondo","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103252","article-title":"Pomalidomide ameliorates H2O2-induced oxidative stress injury and cell death in rat primary cortical neuronal cultures by inducing anti-oxidative and anti-apoptosis effects.","volume":"19","author":"Tsai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B336","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0963689719850078","article-title":"Pomalidomide reduces ischemic brain injury in rodents.","volume":"28","author":"Tsai","year":"2019","journal-title":"Cell Transplant."},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.56","article-title":"Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis.","volume":"4","author":"Tursich","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S67655","article-title":"Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.","volume":"8","author":"Tuttolomondo","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-106","article-title":"Tumor necrosis factor-\u03b1 synthesis inhibitor 3,6\u2019-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease.","volume":"9","author":"Tweedie","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B340","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneumeth.2009.06.034","article-title":"A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.","volume":"183","author":"Tweedie","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"B341","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the stanley neuropathology consortium.","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr. Res."},{"key":"B342","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-020-00011-5","article-title":"Top product forecasts for 2020.","volume":"19","author":"Urquhart","year":"2020","journal-title":"Nature Rev Drug Discov."},{"key":"B343","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/IJICMR.S64894","article-title":"TNF-\u03b1 in the cardiovascular system: from physiology to therapy.","volume":"7","author":"Urschel","year":"2015","journal-title":"Int. J. Interf. Cytokine Mediat. Res."},{"key":"B344","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0320-x","article-title":"Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson\u2019s disease.","volume":"12","author":"Valera","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B345","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.neurobiolaging.2015.01.014","article-title":"FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an \u03b1-synuclein-based rat model for Parkinson\u2019s disease.","volume":"36","author":"Van der Perren","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B346","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.metabol.2017.01.014","article-title":"Alzheimer\u2019s disease: innate immunity gone awry?","author":"VanItallie","year":"2017","journal-title":"Metabolism"},{"key":"B347","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms.","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res. Part C Embryo Today Rev."},{"key":"B348","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1753193418805249","article-title":"The teratogenic effects of thalidomide on limbs.","volume":"44","author":"Vargesson","year":"2019","journal-title":"J. Hand Surg. Eur."},{"key":"B349","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eurpsy.2011.11.007","article-title":"The clinical implications of cognitive impairment and allostatic load in bipolar disorder.","volume":"28","author":"Vieta","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"B350","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jnc.13249","article-title":"Structure, function and toxicity of alpha-synuclein: the bermuda triangle in synucleinopathies.","volume":"139","author":"Villar-Piqu\u00e9","year":"2016","journal-title":"J. Neurochem."},{"key":"B351","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2217\/bmm-2016-0366","article-title":"The systemic synuclein sampling study: toward a biomarker for Parkinson\u2019s disease.","volume":"11","author":"Visanji","year":"2017","journal-title":"Biomark. Med."},{"key":"B352","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0668-6","article-title":"Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.","volume":"13","author":"Wang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.119","article-title":"Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.","volume":"4","author":"Watkins","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B355","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuroscience.2005.02.037","article-title":"Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.","volume":"133","author":"Webster","year":"2005","journal-title":"Neuroscience"},{"key":"B356","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbi.2020.10.013","article-title":"Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17\/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors.","volume":"91","author":"Westfall","year":"2021","journal-title":"Brain. Behav. Immun."},{"key":"B357","year":"2001","journal-title":"The World Health Report 2001 - Mental Health: New Understanding, New Hope."},{"key":"B358","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.28015","article-title":"Cerebrospinal fluid cytokines and neurodegeneration-associated proteins in Parkinson\u2019s disease.","volume":"35","author":"Wijeyekoon","year":"2020","journal-title":"Mov. Disord."},{"key":"B359","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD).","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"B360","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0706743718773728","article-title":"An overview of animal models related to schizophrenia.","volume":"64","author":"Winship","year":"2019","journal-title":"Can. J. Psychiatry."},{"key":"B361","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation.","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"B362","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/acn3.50837","article-title":"Translocator protein in late stage Alzheimer\u2019s disease and Dementia with Lewy bodies brains.","volume":"6","author":"Xu","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B363","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-and tumor necrosis factor-regulate amyloid-plaque deposition and-secretase expression in swedish mutant APP transgenic mice.","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B364","doi-asserted-by":"publisher","first-page":"866.e8","DOI":"10.1016\/j.chembiol.2020.04.008","article-title":"A Cell-based target engagement assay for the identification of cereblon E3 ubiquitin ligase ligands and their application in HDAC6 degraders ll a cell-based target engagement assay for the identification of cereblon E3 ubiquitin ligase ligands and their A.","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"B365","first-page":"18","article-title":"The blood brain barrier and the role of cytokines in neuropsychiatry.","volume":"6","author":"Yarlagadda","year":"2009","journal-title":"Psychiatry"},{"key":"B366","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0155","article-title":"A metaplasticity view of the interaction between homeostatic and hebbian plasticity.","volume":"372","author":"Yee","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"B367","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23190","article-title":"3,6\u2019-Dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation HHS public access.","volume":"91","author":"Yoon","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"B368","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00785","article-title":"PT320, sustained-release exendin-4, mitigates L-DOPA-induced dyskinesia in a rat 6-hydroxydopamine model of Parkinson\u2019s disease.","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses.","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B370","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease.","volume":"9","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"B371","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1096\/fj.201600751R","article-title":"Neuroprotective effects of fingolimod in mouse models of Parkinson\u2019s disease.","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J."},{"key":"B372","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1021\/jm030152f","article-title":"Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-\u03b1 inhibitory activity.","volume":"46","author":"Zhu","year":"2003","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.656921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:45:00Z","timestamp":1724719500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.656921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":372,"alternative-id":["10.3389\/fnins.2021.656921"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.656921","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"article-number":"656921"}}